高级搜索

放化疗综合治疗非霍奇金淋巴瘤远期疗效

李方明, 袁卓庭, 汪声恒, 孙亨玉

李方明, 袁卓庭, 汪声恒, 孙亨玉. 放化疗综合治疗非霍奇金淋巴瘤远期疗效[J]. 肿瘤防治研究, 1998, 25(3): 201-203.
引用本文: 李方明, 袁卓庭, 汪声恒, 孙亨玉. 放化疗综合治疗非霍奇金淋巴瘤远期疗效[J]. 肿瘤防治研究, 1998, 25(3): 201-203.
Li Fangming, . Treatment of Non - Hodgkin's Lymphomas with Combined Radio-Chemotherapy[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 201-203.
Citation: Li Fangming, . Treatment of Non - Hodgkin's Lymphomas with Combined Radio-Chemotherapy[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 201-203.

放化疗综合治疗非霍奇金淋巴瘤远期疗效

Treatment of Non - Hodgkin's Lymphomas with Combined Radio-Chemotherapy

  • 摘要: 作者对72例NHL的治疗方法与预后的关系进行临床探讨。本组结外NHL居多占70.8%,Ⅲ、Ⅳ期病人占45.8%。所有病例均经病理证实。其中22例接受扩大野放射治疗(R组);50例接受放化疗综合治疗(RC)组。全组3、5、10、15和>18年生存率分别为61.1%、54.0%、43.8%、35.0%和31.3%。其中R组3、5、10、15和18年以上生存率分别为59.1%、53.2%、23.3%、11.1%和(0/5);RC组分别为61.4%、57.7%、53.2%、41.1%和38.3%。尽管RC组病情较R组严重,但其各年生存率均高于R组,尤以10年以上生存差别显著。初步结果显示放化疗综合治疗NHL是提高远期生存率的有效方法之一。

     

    Abstract: Theraputic result of 72 patients with non Hodgkin's lymphomas (NHL) are evaluated. 70.8% of the cases were out of the lymph nodes, 45.8% at Ⅲ、Ⅳstage. Allpathologically comfirmed. 22 patients received extansion field radiotherapy (R); 50 pa-tients received radiotherapy combined with chemotherapy (RC). The overall survivalrates of 3、5、10、15 and18yean were 61.1 %、54.0%、43.8%、35.0% 、and 31.3%, respectively. the 3、5 、10、15 and 18 year survival rates were 59.1%、53.2%、23.3%、11.l% and (0/5)in R group; 61.4% 、57.7% 、53.2% 、41.1% and 38.3% in RC group,re-spectively. Although the condition of the patients in RC group was more severe than Rgroup, The long term survival rates in RC group were higher than those in R group.The preliminary results shown that radiotherapy combined with chemotherapy is moreeffective in improving long term survival rates for NHL than radiotherapy alone.

     

  • 1. 勇威本, 张运涛, 卫燕, 等. 200例非霍奇金淋巴瘤预后分析. 中华肿瘤杂志, 1997, 19(3):212
    2. The International Non-Hodgkin’s Lymphoma Prognostic Factor Project. A predictive model for aggressive non-Hodgkin’s Lymphoma. N Engl J Med, 1993, 329:987
    3. A. Daban, T. Fouillard. Ⅰ、Ⅱ期高度恶性非何杰金氏淋巴瘤的综合治疗. 中国放射肿瘤学, 1991, 5(4):235
    4. 黄一容, 顾大中, 王奇璐, 等. 恶性淋巴瘤的综合治疗. 中华放射肿瘤学杂志, 1997, 6(2):77
    5. 胡久望. 非何杰金淋巴瘤的综合治疗. 中国放射肿瘤学, 1990, 4(2):127
    6. 王奇璐, 宋少章, 徐宾河, 等. 非何杰金氏淋巴瘤276例化疗有/无放疗临床研究. 肿瘤防治研究, 1991, 19:163
    7. 周立强, 王奇璐, 冯奉仪, 等. 98例晚期NHL疗效和毒性观察. 中华放射肿瘤学杂志, 1994, 3(3):176
计量
  • 文章访问数:  1019
  • HTML全文浏览量:  24
  • PDF下载量:  242
  • 被引次数: 0
出版历程
  • 刊出日期:  1998-06-04

目录

    /

    返回文章
    返回
    x 关闭 永久关闭